Clinical Trial Update: Neuropathic Pain in Patients With Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by DARA Therapeutics evaluating treatment for neuropathic pain in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Neuropathic Pain

Snippet

Sponsor: DARA Therapeutics | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED